Sasta ParchaWahi dawai. Sahi daam.

Salt / ingredient

Chlorthalidone 6.25mg + Olmesartan Medoxomil 40mg

Lowers blood pressure

MRP data last verified: August 2026. Source: NPPA Pharma Sahi Daam, reproduced under the NPPA copyright policy.

More about this medicine

Reference information

About Chlorthalidone

Source: OpenFDA

This information is from US FDA labels, for reference only. Always follow your doctor's advice.

Common side effects
  • nausea
  • hyperuricemia
  • dizziness
  • upper respiratory infection ( 6
Safety advice
  • Consult your doctor before use if pregnant or breastfeeding.
  • May affect the kidneys. Tell your doctor if you have kidney problems.
  • Stop use and seek emergency help if you have signs of a severe allergic reaction.
Uses
  • lmesartan medoxomil and hydrochlorothiazide is indicated for the treatment of hypertension, to lower blood pressure.
  • Olmesartan medoxomil and hydrochlorothiazide is not indicated for the initial therapy of hypertension .
  • Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions.
  • These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs.
  • There are no controlled trials demonstrating risk reduction with olmesartan medoxomil and hydrochlorothiazide.
How to take
  • he recommended starting dose of olmesartan medoxomil and hydrochlorothiazide is 40/12.5 mg once daily in patients whose blood pressure is not adequately controlled with olmesartan monotherapy.
  • Dose can be titrated up to 40 /25 mg if necessary.
  • The recommended starting dose of olmesartan medoxomil and hydrochlorothiazide is 20/12.5 mg once daily in patients whose blood pressure is not adequately controlled with monotherapy or who experience dose-limiting adverse reactions with hydrochlorothiazide.
  • Patients titrated to the individual components (olmesartan and hydrochlorothiazide) may instead receive the corresponding dose of olmesartan medoxomil and hydrochlorothiazide.
  • Recommended starting dose in patients not adequately controlled with olmesartan monotherapy, 40/12.5 mg ( 2 ) Recommended starting dose in patients not adequately controlled with hydrochlorothiazide monotherapy, 20/12.5 mg ( 2 ) Adjust dose after 2 to 4 weeks, as needed, to a maximum of 40 mg / 25 mg olmesartan / hydrochlorothiazide ( 2 )

Frequently Asked Questions about Chlorthalidone 6.25mg + Olmesartan Medoxomil 40mg

What is the price of Chlorthalidone 6.25mg + Olmesartan Medoxomil 40mg in India?

The price of Chlorthalidone 6.25mg + Olmesartan Medoxomil 40mg in India depends on the manufacturer and channel.Private commercial brands vary from low-cost options to higher-priced branded formulations.

Is a Government Jan Aushadhi generic available for Chlorthalidone 6.25mg + Olmesartan Medoxomil 40mg?

Jan Aushadhi generic availability varies. Use the Nearby Kendra locator on Sasta Parcha to find nearby government stores.

How to find lower-cost substitutes for Chlorthalidone 6.25mg + Olmesartan Medoxomil 40mg?

Search the active salt formulation (Chlorthalidone 6.25mg + Olmesartan Medoxomil 40mg) on Sasta Parcha to view private-brand substitutes ranked strictly low-to-high by per-unit price. Always consult your prescribing doctor or pharmacist before changing medicine brands.